TRASTUZMAB OR A TKI ACTIVATES NOTCH 1 IN BREAST CANCER: NOVEL THERAPEUTIC OPPORTUNITIES USING NOTCH INHIBITORS
$445,501FY2008Department of the ArmyDOD
Loyola University Of Chicago, Chicago IL
Investigators
View source on USAspending →TRASTUZMAB OR A TKI ACTIVATES NOTCH 1 IN BREAST CANCER: NOVEL THERAPEUTIC OPPORTUNITIES USING NOTCH INHIBITORS · GrantIndex